Furthermore, it enhances the maturation of T helper cells into the CD4+CD25+Foxp3+Treg pathways, which can inhibit effector T cell responses and thus reduce anti-tumour immunity [98,99,100,101,102,103,104]. Here, FOXP3 is linked to neoplasm.